Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Diana Z, Paderina"'
Autor:
Irina A. Mednova, Ivan V. Pozhidaev, Vladimir V. Tiguntsev, Anna V. Bocharova, Diana Z. Paderina, Anastasiia S. Boiko, Olga Y. Fedorenko, Elena G. Kornetova, Nikolay A. Bokhan, Vadim A. Stepanov, Svetlana A. Ivanova
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 627 (2024)
Metabolic syndrome (MetS) is common among schizophrenia patients, and one of MetS’s causes may be an imbalance in nitric oxide regulation. In this study, we examined associations of three polymorphic variants of the nitric oxide synthase 1 adapter
Externí odkaz:
https://doaj.org/article/cecf2a78384a4a8580dd4cb5d01a999b
Autor:
Olga Yu. Fedorenko, Diana Z. Paderina, Elena G. Kornetova, Evgeniya G. Poltavskaya, Ivan V. Pozhidaev, Anastasiia A. Goncharova, Maxim B. Freidin, Anna V. Bocharova, Nikolay A. Bokhan, Anton J. M. Loonen, Svetlana A. Ivanova
Publikováno v:
Diagnostics, Vol 12, Iss 7, p 1521 (2022)
Background: Tardive dyskinesia (TD) is an extrapyramidal side effect of the long-term use of antipsychotics. In the present study, the role of glutamatergic system genes in the pathogenesis of total TD, as well as two phenotypic forms, orofacial TD a
Externí odkaz:
https://doaj.org/article/46a641cce0734176970746a71013837b
Autor:
Ivan V. Pozhidaev, Diana Z. Paderina, Olga Yu. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Anton J. M. Loonen, Nikolay A. Bokhan, Bob Wilffert, Svetlana A. Ivanova
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 13 (2020)
BackgroundTardive dyskinesia (TD) is a common side effect of antipsychotic treatment. This movement disorder consists of orofacial and limb-truncal components. The present study is aimed at investigating the role of serotonin receptors (HTR) in modul
Externí odkaz:
https://doaj.org/article/6d783e5a7d8245928975411558f6d60b
Autor:
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Anton J. M. Loonen, German G. Simutkin, Nikolay A. Bokhan, Svetlana A. Ivanova, Bob Wilffert
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Major depressive disorder has become a prominent cause of disability, as lifetime prevalence has increased to ~15% in the Western world. Pharmacological effects of serotonin (5-hydroxytryptamine, 5-HT) are mediated through 5-hydroxytryptamine recepto
Externí odkaz:
https://doaj.org/article/bb120c8f653248e694bb302cf57bee55
Autor:
Evgeniya G. Poltavskaya, Elena G. Kornetova, Maxim B. Freidin, Ivan V. Pozhidaev, Diana Z. Paderina, Anna V. Bocharova, Arkadiy V. Semke, Nikolay A. Bokhan, Svetlana A. Ivanova, Olga Y. Fedorenko
Publikováno v:
Genes
Volume 14
Issue 3
Pages: 575
Volume 14
Issue 3
Pages: 575
Background: Personal variations in genetic risk for schizophrenia relate to its phenotypic heterogeneity—both in disorder development and clinical manifestations. Abnormal glutamatergic neurotransmitter system functioning is integrated in the patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6a327da0de396fe523a0c447d8996a2
Autor:
Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov, Diana Z. Paderina, Ivan V. Pozhidaev, Anton J.M. Loonen, German G. Simutkin, Nikolay A. Bokhan, Bob Wilffert, Svetlana A. Ivanova
Publikováno v:
Neuroscience Applied, 2:101016. Elsevier
Mood disorders are a prevalent mental health disorder. The adrenergic neurotransmission pathway presents an opportunity to determine whether genetic mutations impact antidepressant response. For this study, 163 patients with major depressive disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2fa162dea370182bb4a33906d5b1f49
https://doi.org/10.1016/j.nsa.2022.101016
https://doi.org/10.1016/j.nsa.2022.101016
Autor:
Nikolay A. Bokhan, Ivan V Pozhidaev, Elena G Kornetova, Anastasiia S Boiko, Diana Z Paderina, A. V. Bocharova, Anton J. M. Loonen, Arkadiy V. Semke, Irina A. Mednova, Olga Yu Fedorenko, Svetlana A. Ivanova
Publikováno v:
Pharmacogenomics and personalized medicine, 14, 1123-1131
Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
Anastasiia S Boiko,1,* Ivan V Pozhidaev,1,* Diana Z Paderina,1 Anna V Bocharova,2 Irina A Mednova,1 Olga Yu Fedorenko,1 Elena G Kornetova,3,4 Anton JM Loonen,5 Arkadiy V Semke,3 Nikolay A Bokhan,6,7 Svetlana A Ivanova1,7 1Molecular Genetics a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7285a9640cad36b78bed96f6fd7779c
https://research.rug.nl/en/publications/bca906dc-6dba-4c8d-bc66-ab9e8328ad9a
https://research.rug.nl/en/publications/bca906dc-6dba-4c8d-bc66-ab9e8328ad9a
Autor:
Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev, Irina A. Mednova, Anastasia A. Goncharova, Anna V. Bocharova, Olga Yu. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan, Anton J. M. Loonen, Svetlana A. Ivanova
Publikováno v:
Genes, 13(8):1312. MDPI AG
Genes; Volume 13; Issue 8; Pages: 1312
Genes; Volume 13; Issue 8; Pages: 1312
BACKGROUND: Metabolic syndrome is widespread in patients with schizophrenia receiving long-term antipsychotic therapy. Dopamine D2 receptors play an important role in mediating both the therapeutic actions of antipsychotics and their side effects. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9cd6380be95eb5e0073efdae2828bc4
https://research.rug.nl/en/publications/6a46b905-29e8-4eac-ac38-7e520ea78fe3
https://research.rug.nl/en/publications/6a46b905-29e8-4eac-ac38-7e520ea78fe3
Autor:
Anastasiia S. Boiko, Ivan V. Pozhidaev, Diana Z. Paderina, Irina A. Mednova, Anastasya A. Goncharova, Olga Yu. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan, Anton J. M. Loonen, Svetlana A. Ivanova
Publikováno v:
Genes; Volume 13; Issue 5; Pages: 844
Genes, 13(5):844. MDPI AG
Genes, 13(5):844. MDPI AG
Background: Metabolic syndrome (MetS) is a common complication of long-term treatment of persons with schizophrenia taking (atypical) antipsychotics. In this study, we investigated the existence of an association with polymorphisms of genes for four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57de7d1fec0f228075383e707d448d79
Autor:
Gennadiy Tenin, Anton J. M. Loonen, Nikolay A. Bokhan, Elena G Kornetova, Diana Z Paderina, Bob Wilffert, Anastasiia S Boiko, Svetlana A. Ivanova, Olga Yu Fedorenko, Arkadiy V. Semke, Ivan V Pozhidaev
Publikováno v:
The Application of Clinical Genetics. 13:97-105
Background Previous studies have linked muscarinic M4 receptors (CHRM4) to schizophrenia. Specifically, the rs2067482 polymorphism was found to be highly associated with this disease. Purpose To test whether rs2067482 and rs72910092 are potential ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::928ccb11b43eceb14ad9414af019775e
https://doi.org/10.2147/tacg.s247174
https://doi.org/10.2147/tacg.s247174